JPMorgan U.S. Research Enhanced Equity Fund Class A EBIT

As of the most recent data (June 2025), JDEAX shows a EBIT of $110B. That compares with $24B in the prior-year period — up 380.9% year over year. That is above the sector sector average of $-25M. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JDEAX's EBIT is now $110B (was $24B) — a 380.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether JPMorgan U.S. Research Enhanced Equity Fund Class A is outperforming or lagging.

The its sector sector average EBIT is about $-25M. JPMorgan U.S. Research Enhanced Equity Fund Class A is at $110B, which is higher that average. That is roughly 448661.5% above the sector mean. Use the comparison chart on this page to see how JDEAX stacks up against individual peers as well.

Tracking JDEAX's ebit over time shows whether JPMorgan U.S. Research Enhanced Equity Fund Class A is scaling, shrinking, or reshaping that part of the business. The current reading is $110B That compares with $24B in the prior-year period — up 380.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has JPMorgan U.S. Research Enhanced Equity Fund Class A's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $110B) with ownership activity and broader fundamentals.